Geode Capital Management, LLC Indaptus Therapeutics, Inc. Transaction History
Geode Capital Management, LLC
- $1.12 Trillion
- Q2 2024
A detailed history of Geode Capital Management, LLC transactions in Indaptus Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 59,309 shares of INDP stock, worth $71,170. This represents 0.0% of its overall portfolio holdings.
Number of Shares
59,309
Previous 54,767
8.29%
Holding current value
$71,170
Previous $122,000
2.46%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding INDP
# of Institutions
20Shares Held
600KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA256KShares$307,5180.0% of portfolio
-
Investment House LLC Las Vegas, NV102KShares$122,9240.01% of portfolio
-
Strategy Asset Managers LLC45.3KShares$54,4030.02% of portfolio
-
Pine Valley Investments LTD Liability CO Marlton, NJ44.1KShares$52,9020.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny26.6KShares$31,9200.0% of portfolio
About Indaptus Therapeutics, Inc.
- Ticker INDP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,258,600
- Market Cap $9.91M
- Description
- Indaptus Therapeutics, Inc., a pre-clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical oncology candidate is Decoy20 to single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as hepatitis B v...